Physician profile
Nirali D Soni
NPI 1598106726
$5,811.36
in general payments reported to CMS, 2019-2025
49 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,452 · 2020: $556 · 2021: $144 · 2022: $383 · 2023: $635 · 2024: $587 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.30 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $927.30 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Novartis Pharmaceuticals Corporation | $420.77 | 2019-2020 | |
| Lundbeck LLC | $315.27 | 2019-2025 | Vyepti, Rexulti |
| Amgen INC. | $306.79 | 2019-2025 | Uplizna, Aimovig |
| Ucb, INC. | $265.45 | 2019-2025 | Briviact, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $244.66 | 2019-2025 | Ajovy |
| Allergan, INC. | $232.30 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $229.25 | 2019-2023 | |
| Eisai INC. | $207.92 | 2019-2025 | |
| Biogen, INC. | $207.84 | 2019-2020 | |
| Emd Serono, INC. | $174.48 | 2019-2020 | |
| Lilly USA, LLC | $168.84 | 2019-2025 | Amyvid, Kisunla, Zepbound |
| Sunovion Pharmaceuticals INC. | $164.44 | 2019 | |
| Sk Life Science, INC. | $154.89 | 2020-2025 | |
| Genentech USA, INC. | $153.15 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirali Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.